nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.609	1	CbGbCtD
Isoprenaline—ADRBK1—peripheral nervous system—amyotrophic lateral sclerosis	0.0124	0.122	CbGeAlD
Isoprenaline—MAPK1—hindbrain—amyotrophic lateral sclerosis	0.00713	0.0701	CbGeAlD
Isoprenaline—PIK3R2—nervous system—amyotrophic lateral sclerosis	0.00542	0.0533	CbGeAlD
Isoprenaline—PIK3R2—central nervous system—amyotrophic lateral sclerosis	0.00521	0.0513	CbGeAlD
Isoprenaline—PIK3R2—cerebellum—amyotrophic lateral sclerosis	0.0051	0.0502	CbGeAlD
Isoprenaline—ADRBK1—embryo—amyotrophic lateral sclerosis	0.00452	0.0445	CbGeAlD
Isoprenaline—MAPK1—embryo—amyotrophic lateral sclerosis	0.00446	0.0439	CbGeAlD
Isoprenaline—PIK3R1—medulla oblongata—amyotrophic lateral sclerosis	0.00418	0.0411	CbGeAlD
Isoprenaline—PIK3R2—brain—amyotrophic lateral sclerosis	0.00414	0.0407	CbGeAlD
Isoprenaline—MAPK1—brainstem—amyotrophic lateral sclerosis	0.00409	0.0402	CbGeAlD
Isoprenaline—PIK3R1—spinal cord—amyotrophic lateral sclerosis	0.00373	0.0367	CbGeAlD
Isoprenaline—PIK3R3—nervous system—amyotrophic lateral sclerosis	0.00368	0.0362	CbGeAlD
Isoprenaline—PIK3R3—central nervous system—amyotrophic lateral sclerosis	0.00354	0.0348	CbGeAlD
Isoprenaline—PIK3R3—cerebellum—amyotrophic lateral sclerosis	0.00346	0.034	CbGeAlD
Isoprenaline—PIK3R1—cerebellum—amyotrophic lateral sclerosis	0.00295	0.0291	CbGeAlD
Isoprenaline—PIK3R3—brain—amyotrophic lateral sclerosis	0.00281	0.0276	CbGeAlD
Isoprenaline—MAPK1—spinal cord—amyotrophic lateral sclerosis	0.00254	0.025	CbGeAlD
Isoprenaline—PIK3R1—brain—amyotrophic lateral sclerosis	0.0024	0.0236	CbGeAlD
Isoprenaline—ADRBK1—nervous system—amyotrophic lateral sclerosis	0.00217	0.0214	CbGeAlD
Isoprenaline—MAPK1—nervous system—amyotrophic lateral sclerosis	0.00214	0.0211	CbGeAlD
Isoprenaline—ADRBK1—central nervous system—amyotrophic lateral sclerosis	0.00209	0.0206	CbGeAlD
Isoprenaline—MAPK1—central nervous system—amyotrophic lateral sclerosis	0.00206	0.0203	CbGeAlD
Isoprenaline—ADRBK1—cerebellum—amyotrophic lateral sclerosis	0.00204	0.0201	CbGeAlD
Isoprenaline—MAPK1—cerebellum—amyotrophic lateral sclerosis	0.00201	0.0198	CbGeAlD
Isoprenaline—ADRBK1—brain—amyotrophic lateral sclerosis	0.00166	0.0163	CbGeAlD
Isoprenaline—MAPK1—brain—amyotrophic lateral sclerosis	0.00164	0.0161	CbGeAlD
Isoprenaline—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.0012	0.104	CcSEcCtD
Isoprenaline—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.000928	0.0805	CcSEcCtD
Isoprenaline—ADRB1—nervous system—amyotrophic lateral sclerosis	0.000909	0.00894	CbGeAlD
Isoprenaline—ADRB1—central nervous system—amyotrophic lateral sclerosis	0.000875	0.00861	CbGeAlD
Isoprenaline—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.000822	0.0713	CcSEcCtD
Isoprenaline—Sweating—Riluzole—amyotrophic lateral sclerosis	0.000721	0.0626	CcSEcCtD
Isoprenaline—ADRB1—brain—amyotrophic lateral sclerosis	0.000695	0.00683	CbGeAlD
Isoprenaline—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000603	0.0523	CcSEcCtD
Isoprenaline—CYP1A1—nervous system—amyotrophic lateral sclerosis	0.000586	0.00577	CbGeAlD
Isoprenaline—Tension—Riluzole—amyotrophic lateral sclerosis	0.000577	0.0501	CcSEcCtD
Isoprenaline—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000571	0.0495	CcSEcCtD
Isoprenaline—CYP1A1—central nervous system—amyotrophic lateral sclerosis	0.000564	0.00555	CbGeAlD
Isoprenaline—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000551	0.0478	CcSEcCtD
Isoprenaline—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000528	0.0458	CcSEcCtD
Isoprenaline—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000519	0.0451	CcSEcCtD
Isoprenaline—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000509	0.0442	CcSEcCtD
Isoprenaline—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000507	0.044	CcSEcCtD
Isoprenaline—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000468	0.0406	CcSEcCtD
Isoprenaline—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000464	0.0402	CcSEcCtD
Isoprenaline—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000448	0.0389	CcSEcCtD
Isoprenaline—CYP1A1—brain—amyotrophic lateral sclerosis	0.000448	0.00441	CbGeAlD
Isoprenaline—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000434	0.0377	CcSEcCtD
Isoprenaline—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000428	0.0371	CcSEcCtD
Isoprenaline—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000344	0.0299	CcSEcCtD
Isoprenaline—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000317	0.0275	CcSEcCtD
Isoprenaline—Headache—Riluzole—amyotrophic lateral sclerosis	0.000301	0.0261	CcSEcCtD
Isoprenaline—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000285	0.0247	CcSEcCtD
Isoprenaline—ADRB3—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	6.18e-05	0.000223	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—CASP9—amyotrophic lateral sclerosis	6.16e-05	0.000222	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—SOD1—amyotrophic lateral sclerosis	6.14e-05	0.000221	CbGpPWpGaD
Isoprenaline—ADRB1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	6.09e-05	0.000219	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.07e-05	0.000219	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—VAPB—amyotrophic lateral sclerosis	6.04e-05	0.000218	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—TPK1—amyotrophic lateral sclerosis	6.04e-05	0.000218	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—CASP9—amyotrophic lateral sclerosis	6.02e-05	0.000217	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	6.01e-05	0.000216	CbGpPWpGaD
Isoprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	5.96e-05	0.000215	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—CASP9—amyotrophic lateral sclerosis	5.93e-05	0.000213	CbGpPWpGaD
Isoprenaline—MAPK1—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	5.92e-05	0.000213	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.92e-05	0.000213	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—SQSTM1—amyotrophic lateral sclerosis	5.91e-05	0.000213	CbGpPWpGaD
Isoprenaline—MAPK1—Oxidative Stress Induced Senescence—TP53—amyotrophic lateral sclerosis	5.88e-05	0.000212	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	5.88e-05	0.000212	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—C3—amyotrophic lateral sclerosis	5.81e-05	0.000209	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	5.74e-05	0.000207	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	5.65e-05	0.000204	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.63e-05	0.000203	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	5.63e-05	0.000203	CbGpPWpGaD
Isoprenaline—PIK3R2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	5.59e-05	0.000201	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—ERBB4—amyotrophic lateral sclerosis	5.58e-05	0.000201	CbGpPWpGaD
Isoprenaline—PIK3R3—Hemostasis—VEGFA—amyotrophic lateral sclerosis	5.57e-05	0.000201	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	5.56e-05	0.0002	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.55e-05	0.0002	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—ATF1—amyotrophic lateral sclerosis	5.54e-05	0.0002	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.54e-05	0.000199	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	5.52e-05	0.000199	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—IGF1—amyotrophic lateral sclerosis	5.51e-05	0.000198	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	5.51e-05	0.000198	CbGpPWpGaD
Isoprenaline—ADRBK1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	5.5e-05	0.000198	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—ERBB4—amyotrophic lateral sclerosis	5.49e-05	0.000198	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	5.49e-05	0.000198	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	5.45e-05	0.000196	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	5.43e-05	0.000195	CbGpPWpGaD
Isoprenaline—MAPK1—TGF-beta Signaling Pathway—TP53—amyotrophic lateral sclerosis	5.42e-05	0.000195	CbGpPWpGaD
Isoprenaline—MAPK1—Focal Adhesion—VEGFA—amyotrophic lateral sclerosis	5.36e-05	0.000193	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	5.34e-05	0.000192	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	5.33e-05	0.000192	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.29e-05	0.00019	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CASP9—amyotrophic lateral sclerosis	5.28e-05	0.00019	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	5.27e-05	0.00019	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—CD40LG—amyotrophic lateral sclerosis	5.24e-05	0.000189	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—CD40LG—amyotrophic lateral sclerosis	5.17e-05	0.000186	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—ERBB4—amyotrophic lateral sclerosis	5.15e-05	0.000185	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.14e-05	0.000185	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.13e-05	0.000185	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.09e-05	0.000183	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—ERBB4—amyotrophic lateral sclerosis	5.07e-05	0.000183	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.07e-05	0.000183	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—APOE—amyotrophic lateral sclerosis	5e-05	0.00018	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5e-05	0.00018	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	4.99e-05	0.00018	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—CASP9—amyotrophic lateral sclerosis	4.87e-05	0.000176	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	4.86e-05	0.000175	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	4.83e-05	0.000174	CbGpPWpGaD
Isoprenaline—MAPK1—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	4.75e-05	0.000171	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.72e-05	0.00017	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	4.69e-05	0.000169	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	4.65e-05	0.000167	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.65e-05	0.000167	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	4.64e-05	0.000167	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—C3—amyotrophic lateral sclerosis	4.63e-05	0.000167	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—C3—amyotrophic lateral sclerosis	4.57e-05	0.000164	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CST3—amyotrophic lateral sclerosis	4.56e-05	0.000164	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	4.55e-05	0.000164	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	4.54e-05	0.000163	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	4.54e-05	0.000163	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.53e-05	0.000163	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.52e-05	0.000163	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—ERBB4—amyotrophic lateral sclerosis	4.52e-05	0.000163	CbGpPWpGaD
Isoprenaline—MAPK1—MAPK Signaling Pathway—TP53—amyotrophic lateral sclerosis	4.47e-05	0.000161	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	4.45e-05	0.00016	CbGpPWpGaD
Isoprenaline—PIK3R2—Hemostasis—VEGFA—amyotrophic lateral sclerosis	4.44e-05	0.00016	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.42e-05	0.000159	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.42e-05	0.000159	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.41e-05	0.000159	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—C3—amyotrophic lateral sclerosis	4.38e-05	0.000158	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	4.37e-05	0.000157	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.36e-05	0.000157	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	4.31e-05	0.000155	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.25e-05	0.000153	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	4.25e-05	0.000153	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CD40LG—amyotrophic lateral sclerosis	4.25e-05	0.000153	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.21e-05	0.000152	CbGpPWpGaD
Isoprenaline—PIK3R3—Hemostasis—TP53—amyotrophic lateral sclerosis	4.21e-05	0.000152	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—APOE—amyotrophic lateral sclerosis	4.19e-05	0.000151	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—ERBB4—amyotrophic lateral sclerosis	4.17e-05	0.00015	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	4.16e-05	0.00015	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.16e-05	0.00015	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.15e-05	0.000149	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—VEGFA—amyotrophic lateral sclerosis	4.12e-05	0.000148	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular Senescence—TP53—amyotrophic lateral sclerosis	4.12e-05	0.000148	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.11e-05	0.000148	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.06e-05	0.000146	CbGpPWpGaD
Isoprenaline—MAPK1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	4.03e-05	0.000145	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—SQSTM1—amyotrophic lateral sclerosis	4.02e-05	0.000145	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	4.01e-05	0.000144	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	4e-05	0.000144	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—APOE—amyotrophic lateral sclerosis	3.98e-05	0.000143	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—APOE—amyotrophic lateral sclerosis	3.92e-05	0.000141	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	3.91e-05	0.000141	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—MMP9—amyotrophic lateral sclerosis	3.89e-05	0.00014	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	3.82e-05	0.000138	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.82e-05	0.000138	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	3.79e-05	0.000136	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	3.78e-05	0.000136	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—ATF1—amyotrophic lateral sclerosis	3.77e-05	0.000136	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.76e-05	0.000135	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—C3—amyotrophic lateral sclerosis	3.76e-05	0.000135	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—IGF1—amyotrophic lateral sclerosis	3.74e-05	0.000135	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.73e-05	0.000134	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	3.71e-05	0.000133	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	3.67e-05	0.000132	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.61e-05	0.00013	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—VEGFA—amyotrophic lateral sclerosis	3.6e-05	0.00013	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	3.59e-05	0.000129	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CASP9—amyotrophic lateral sclerosis	3.59e-05	0.000129	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.58e-05	0.000129	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.58e-05	0.000129	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.55e-05	0.000128	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.5e-05	0.000126	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.5e-05	0.000126	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—VEGFA—amyotrophic lateral sclerosis	3.49e-05	0.000126	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—PTGS2—amyotrophic lateral sclerosis	3.42e-05	0.000123	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.41e-05	0.000123	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.39e-05	0.000122	CbGpPWpGaD
Isoprenaline—PIK3R2—Hemostasis—TP53—amyotrophic lateral sclerosis	3.36e-05	0.000121	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.34e-05	0.00012	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—APOE—amyotrophic lateral sclerosis	3.34e-05	0.00012	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.33e-05	0.00012	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CASP9—amyotrophic lateral sclerosis	3.31e-05	0.000119	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	3.31e-05	0.000119	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.29e-05	0.000118	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	3.26e-05	0.000117	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—APOE—amyotrophic lateral sclerosis	3.23e-05	0.000116	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	3.22e-05	0.000116	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	3.19e-05	0.000115	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	3.16e-05	0.000114	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	3.15e-05	0.000114	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	3.11e-05	0.000112	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—ERBB4—amyotrophic lateral sclerosis	3.07e-05	0.000111	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	3.05e-05	0.00011	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—C3—amyotrophic lateral sclerosis	3e-05	0.000108	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.95e-05	0.000106	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.92e-05	0.000105	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.89e-05	0.000104	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CD40LG—amyotrophic lateral sclerosis	2.89e-05	0.000104	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.87e-05	0.000103	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.85e-05	0.000103	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—ERBB4—amyotrophic lateral sclerosis	2.84e-05	0.000102	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.79e-05	0.000101	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.79e-05	0.0001	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.78e-05	0.0001	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—MMP9—amyotrophic lateral sclerosis	2.78e-05	0.0001	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.75e-05	9.9e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.75e-05	9.89e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—PTGS2—amyotrophic lateral sclerosis	2.73e-05	9.83e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Hemostasis—TP53—amyotrophic lateral sclerosis	2.72e-05	9.79e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—APOE—amyotrophic lateral sclerosis	2.7e-05	9.73e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.69e-05	9.7e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—PTGS2—amyotrophic lateral sclerosis	2.69e-05	9.68e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.68e-05	9.66e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.64e-05	9.49e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.62e-05	9.44e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.6e-05	9.35e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.56e-05	9.24e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—C3—amyotrophic lateral sclerosis	2.55e-05	9.19e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.51e-05	9.03e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	2.49e-05	8.98e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.45e-05	8.81e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.44e-05	8.77e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.43e-05	8.74e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.38e-05	8.57e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.37e-05	8.53e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.33e-05	8.39e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.32e-05	8.36e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.31e-05	8.3e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.29e-05	8.24e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.29e-05	8.23e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.27e-05	8.18e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.26e-05	8.14e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.23e-05	8.02e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.21e-05	7.97e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—PTGS2—amyotrophic lateral sclerosis	2.21e-05	7.96e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.21e-05	7.94e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—APOE—amyotrophic lateral sclerosis	2.19e-05	7.9e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.17e-05	7.8e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.1e-05	7.57e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.08e-05	7.48e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.03e-05	7.31e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.99e-05	7.15e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.98e-05	7.12e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.93e-05	6.97e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.89e-05	6.8e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.87e-05	6.73e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.87e-05	6.72e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.85e-05	6.67e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—TP53—amyotrophic lateral sclerosis	1.85e-05	6.66e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.82e-05	6.56e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.77e-05	6.39e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.75e-05	6.29e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—TP53—amyotrophic lateral sclerosis	1.74e-05	6.28e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.69e-05	6.1e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.68e-05	6.04e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.66e-05	5.96e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.65e-05	5.95e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.65e-05	5.94e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.59e-05	5.73e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.57e-05	5.65e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.56e-05	5.61e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.54e-05	5.53e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.51e-05	5.42e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—PTGS2—amyotrophic lateral sclerosis	1.5e-05	5.41e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.48e-05	5.34e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.44e-05	5.18e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.43e-05	5.14e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.41e-05	5.06e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.4e-05	5.05e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.38e-05	4.95e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.36e-05	4.89e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.35e-05	4.85e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.33e-05	4.78e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.31e-05	4.72e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.28e-05	4.61e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.27e-05	4.57e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.24e-05	4.46e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.22e-05	4.39e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.19e-05	4.29e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.14e-05	4.1e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.12e-05	4.04e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.08e-05	3.9e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.06e-05	3.81e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	1.02e-05	3.67e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.77e-06	3.52e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.24e-06	3.33e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.22e-06	3.32e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9e-06	3.24e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.33e-06	3e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.29e-06	2.99e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.15e-06	2.93e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.87e-06	2.83e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.7e-06	2.77e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.07e-06	2.54e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.98e-06	2.51e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.91e-06	2.49e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.27e-06	2.26e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.34e-06	1.92e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.22e-06	1.88e-05	CbGpPWpGaD
